The first companies to receive the indicative outcome of their requests for relief from next April's 'catch-up' statutory price reductions have until today to submit additional information if they want a revision. …
Companies start submitting additional information in support of 'relief'
October 25, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
New report highlights widening gap in access to modern medicines between Australia and NZ
October 8, 2025 - - Latest News -
RACGP warns of mounting pressure on GPs as costs and complexity rise
October 7, 2025 - - Other Health -
AusBiotech’s annual report highlights a defining year for Australia’s life sciences sector
October 7, 2025 - - Australian Biotech -
AstraZeneca becomes the latest to say it could halt UK investment over 'appalling' pricing regime
October 7, 2025 - - Latest News -
MTPConnect and Wholesale Investor unite to accelerate investment in life sciences sector
October 7, 2025 - - Australian Biotech -
Percheron Therapeutics reports positive final data from early-phase trial of HMBD-002
October 7, 2025 - - Australian Biotech -
FDA clears clinical hold on Neurizon's NUZ-001, paving way for HEALEY ALS trial
October 7, 2025 - - Australian Biotech